Rockwell Automation’s updated FactoryTalk AssetCentre software supports several new types of production assets.
Image courtesy of Rockwell Automation
The latest version of Rockwell Automation’s FactoryTalk AssetCentre software expands its asset-management and recovery capabilities to support several new types of production assets and protect them from security incidents and lifecycle risks. The new version also supports larger systems and can better protect communications between a user’s assets by using secure communications with FactoryTalk Linx and IPSec adoption.
Disaster-recovery support is now available for FactoryTalk View Site Edition human-machine interface (HMI) applications and Stratix-managed ethernet switches. Users can back up the current state of their custom HMI applications to avoid rebuilding them in the event of a system failure or disaster, minimizing downtime in the production system. They can also back up the configurations of their Stratix 5400, 5700, and 8000 switches, which can help avoid the long and complex process of reconfiguring managed switches following an incident.
Disaster recovery support is also now available for third-party software. The software’s custom-device plug-in capability can be used to automate third-party device-configuration software to do disaster recovery and backup and compare, when supported by the software.
Lifecycle status information is now accessible for Allen-Bradley I/O modules that are used with PLC, SLC 5000, MicroLogix, CompactLogix, and ControlLogix controllers. This information can help users stay on top of where their assets are in their lifecycles, so they can track risks like obsolescence and better plan their modernization strategies.
Source: Rockwell Automation
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Legal and Regulatory Perspectives on 3D Printing: Drug Compounding Applications
December 10th 2024This paper explores the legal and regulatory framework around 3D drug printing, particularly for personalized medicine, considering regulatory compliance, business concerns, and intellectual property rights.